You are here

  • Home
  • Archive
  • Volume 25, Issue 1
  • Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit

Citation Tools

Article menu
Download PDFPDF
Uterine Cancer
Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Otsuki A, Watanabe Y, Nomura H, et al
Paclitaxel and Carboplatin in Patients With Completely or Optimally Resected Carcinosarcoma of the Uterus: A Phase II Trial by the Japanese Uterine Sarcoma Group and the Tohoku Gynecologic Cancer Unit
International Journal of Gynecologic Cancer 2015;25:92-97.